This website is intended for healthcare professionals

National institute for health and care excellence guidelines

Alzheimer’s drug rejected for NHS use over high costs

Donanemab was called a ‘gamechanger,’ but the National Institute for Health and Care Excellence said it did not offer ‘enough benefit to justify the additional cost to the NHS’

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP